EligibleTrials

HerResolve™ in Detecting the Presence of Endometriosis Among Symptomatic Women

Recruiting · NCT07006987 · Interventional (participants receive a specific treatment) · Lead sponsor: Chinese University of Hong Kong

View the official record on ClinicalTrials.gov →
Endometriosis

Interventions studied

A non-invasive blood-based (HerResolve)

What this trial is about

Endometriosis (EMS) is a common gynecological disease that affects 176 million girls and women globally. EMS affects 5-10% of women and adolescents within the reproductive age range of 15-49 years, and for those facing infertility, this figure may climb up to 50%. EMS can start at the first menstrual period and last until menopause. Shockingly, between 50% and 80% of women grappling with pelvic pain are found to have EMS. The formation of scar tissue (adhesions, fibrosis) within the pelvis and other parts of the body can cause severe pain and lead to infertility.

Who can take part

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.